Aehr Test Systems director Howard Slayen sells $758,264 in stock

Howard T. Slayen, director at Aehr Test Systems, sold 5,700 shares of the company's stock on August 14, 2026. The shares were exchanged at $133.0288 each, yielding roughly $758,264 in proceeds from the transaction. As AEHR shares have soared 632% over the past year, currently priced at $134.06, Mr. Slayen's holdings amount to 140,667 shares of common stock, including unvested restricted stock units.

Analysts note the stock as potentially overvalued relative to its fair value estimate, placing it among companies on the Most Overvalued list. Aehr Test Systems recently reported surpassing Wall Street expectations with a fiscal fourth-quarter income of $0.11 per share on $18.8 million in revenue, surpassing earlier estimates of a loss of $0.01 per share and $17.92 million in revenue.

The company also secured record bookings of $60.7 million and a $22 million production order for AI systems, along with a FOX-XP multi-wafer system order, signaling strong growth in AI and silicon photonics markets. Analysts have initiated coverage with a Buy rating from Jefferies and Freedom Broker, citing the company's strategic expansion and projected revenue between $130 million and $150 million for fiscal 2027.